Through the action of TRAFs, CD40/CD40L binding activates the canonical and non-canonical pathway in B cells, and in CLL has induced NF-κB mediated survival (103, 104). This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.